Diagnostic accuracy of 18F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T Journal Article


Authors: Magometschnigg, H. F.; Baltzer, P. A.; Fueger, B.; Helbich, T. H.; Karanikas, G.; Dubsky, P.; Rudas, M.; Weber, M.; Pinker, K.
Article Title: Diagnostic accuracy of 18F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T
Abstract: Purpose: To compare the diagnostic accuracy of prone 18F-FDG PET/CT with that of contrast-enhanced MRI (CE-MRI) at 3 T in suspicious breast lesions. To evaluate the influence of tumour size on diagnostic accuracy and the use of maximum standardized uptake value (SUV<inf>MAX</inf>) thresholds to differentiate malignant from benign breast lesions. Methods: A total of 172 consecutive patients with an imaging abnormality were included in this IRB-approved prospective study. All patients underwent 18F-FDG PET/CT and CE-MRI of the breast at 3 T in the prone position. Two reader teams independently evaluated the likelihood of malignancy as determined by 18F-FDG PET/CT and CE-MRI independently. 18F-FDG PET/CT data were qualitatively evaluated by visual interpretation. Quantitative assessment was performed by calculation of SUV<inf>MAX</inf>. Sensitivity, specificity, diagnostic accuracy, area under the curve and interreader agreement were calculated for all lesions and for lesions <10 mm. Histopathology was used as the standard of reference. Results: There were 132 malignant and 40 benign lesions; 23 lesions (13.4 %) were <10 mm. Both 18F-FDG PET/CT and CE-MRI achieved an overall diagnostic accuracy of 93 %. There were no significant differences in sensitivity (p = 0.125), specificity (p = 0.344) or diagnostic accuracy (p = 1). For lesions <10 mm, diagnostic accuracy deteriorated to 91 % with both 18F-FDG PET/CT and CE-MRI. Although no significant difference was found for lesions <10 mm, CE-MRI at 3 T seemed to be more sensitive but less specific than 18F-FDG PET/CT. Interreader agreement was excellent (κ = 0.85 and κ = 0.92). SUV<inf>MAX</inf> threshold was not helpful in differentiating benign from malignant lesions. Conclusion: 18F-FDG PET/CT and CE-MRI at 3 T showed equal diagnostic accuracies in breast cancer diagnosis. For lesions <10 mm, diagnostic accuracy deteriorated, but was equal for 18F-FDG PET/CT and CE-MRI at 3 T. For lesions <10 mm, CE-MRI at 3 T seemed to be more sensitive but less specific than 18F-FDG PET/CT. Quantitative assessment using an SUV<inf>MAX</inf> threshold for differentiating benign from malignant lesions was not helpful in breast cancer diagnosis. © 2015, Springer-Verlag Berlin Heidelberg.
Keywords: adult; aged; major clinical study; clinical trial; histopathology; comparative study; nuclear magnetic resonance imaging; positron emission tomography; cancer diagnosis; diagnostic accuracy; breast cancer; tumor volume; breast tumor; fluorodeoxyglucose f 18; intermethod comparison; benign tumor; mr imaging; breast lesion; pet/ct; nuclear magnetic resonance scanner; 18f-fdg; interrater reliability; diagnostic test accuracy study; gadoterate meglumine; human; female; article; pet-ct scanner; contrast enhanced magnetic resonance imaging
Journal Title: European Journal of Nuclear Medicine and Molecular Imaging
Volume: 42
Issue: 11
ISSN: 1619-7070
Publisher: Springer  
Date Published: 2015-10-01
Start Page: 1656
End Page: 1665
Language: English
DOI: 10.1007/s00259-015-3099-1
PROVIDER: scopus
PUBMED: 26121928
DOI/URL:
Notes: Export Date: 2 October 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors